While top industry leaders are optimistic about the growth, they expect the special incentives and regulatory streamlining from the government’s side
Granules now has a total of 37 ANDA approvals from US FDA (36 Final approvals and 1 tentative approvals).
Tavaborole Topical Solution, 5%, is an oxaborole antifungal.
Promising drug pipeline, focus on gene therapy and innovative digital health solutions will remain the key pillars of Bayer’s pharmaceutical business
Subscribe To Our Newsletter & Stay Updated
